Skip to Main Content

Paper Details

A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Cancers (Basel)
18
2021
Author NameAffiliation
Tara L LinUniversity of Kansas Cancer Center and Medical Pavillon, University of Kansas
Prapti PatelSouthwestern Medical Center, University of Texas
Christopher R CogleCollege of Medicine, University of Florida
Justin M WattsSylvester Comprehensive Cancer Center, University of Miami
  • 1 - 4

Datasets